Stephens Inc Vericel Corp Transaction History

Stephens Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Mar 07, 2022	SELL	$35.2 - $52.6 $379,420 - $566,975	-10,779 Closed	0 $0
Q3 2021 Oct 27, 2021	SELL	$46.35 - $59.75 $109,246 - $140,830	-2,357 Reduced 17.94%	10,779 $526,000
Q2 2021 Aug 12, 2021	SELL	$47.2 - $67.81 $4,153 - $5,967	-88 Reduced 0.67%	13,136 $690,000
Q1 2021 May 14, 2021	BUY	$30.93 - $59.48 $409,018 - $786,563	13,224 New	13,224 $735,000

275

48.4M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.76B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

Stay updated on Stephens Inc with notifications on news.